Alpha-lipoic acid (ALA) is a popular supplement among older adults, especially those living with diabetes, neuropathy, or metabolic problems. Many products also hint that ALA might “support healthy cholesterol.” A recent systematic review and meta-analysis of randomized controlled trials looked directly at this question: does ALA actually improve the lipid profile?

The researchers pooled clinical trials that gave ALA to adults and measured changes in blood fats such as total cholesterol, LDL, HDL, and triglycerides. Their goal was to see whether ALA meaningfully changed these numbers compared with placebo or control treatments.

What the researchers did

This study was a systematic review and meta-analysis of randomized controlled trials. The authors searched the medical literature for trials that:

• Used alpha-lipoic acid (ALA) as a supplement
• Included a control or placebo group
• Reported lipid outcomes such as total cholesterol, LDL, HDL, and triglycerides

They then combined the results using standard meta-analysis methods to estimate the overall effect of ALA on each lipid marker. In total, the trials were relatively small and varied in dose, duration, and participant health status, which the authors noted as important limitations.

What they found about ALA and lipids

The main finding was that ALA had a , but little to no effect on other cholesterol numbers.

• Triglycerides (TG):
  Across trials, ALA significantly reduced triglyceride levels by about −6.3 mg/dL (95% CI roughly −10.1 to −2.5). However, the authors pointed out that the studies driving this result had a high risk of bias, and overall sample sizes were small with substantial differences between trials.
• Total cholesterol (TC):
  No meaningful change. The pooled effect was close to zero (about +0.3 mg/dL) and not statistically significant.
• LDL cholesterol:
  No significant effect; the combined estimate was very close to no change.
• HDL cholesterol:
  No clear improvement; the pooled effect was small and not statistically significant.

The authors also explored dose and duration. While formal statistics did not show a strong dose–response pattern, they observed that doses up to 1,200 mg/day for about 16 weeks seemed more effective for lowering triglycerides than higher doses or shorter courses.

Comparison: ALA vs placebo

In plain language: in these trials, ALA looked like a modest triglyceride-lowering supplement, not a broad cholesterol-fixing solution. It did not reliably raise HDL or lower LDL.

How strong is this evidence?

The authors were careful to point out several limitations:

• High risk of bias: The trials that contributed most to the triglyceride-lowering effect were judged to have a high risk of bias.
• Small sample sizes: Many studies were small, which makes results less stable and more sensitive to chance.
• Heterogeneity: There was a high degree of variation between studies in dose, duration, and participant characteristics.

Because of these issues, the triglyceride result should be seen as suggestive, not definitive. The meta-analysis highlights a possible benefit, but it does not prove that ALA will meaningfully improve triglycerides for every older adult.

What this means for older adults

For older adults, especially those with metabolic syndrome, type 2 diabetes, or elevated triglycerides, this study suggests that ALA may offer a small additional reduction in triglycerides. It does not appear to be a strong tool for lowering LDL or raising HDL.

If you are already working with your clinician on cholesterol and triglycerides, ALA might be considered as a possible add-on, not a replacement for proven treatments such as statins, diet changes, or physical activity. Any decision should be made with a clinician who understands your full medication list and health history.

Safety and cautions

ALA is generally well tolerated, but there are important cautions for older adults:

• Blood sugar: ALA can lower blood sugar, which may interact with diabetes medications and increase the risk of hypoglycemia.
• Thyroid function: There are case reports and theoretical concerns about interactions with thyroid medications; people with thyroid disease should discuss ALA with their clinician.
• Polypharmacy: If you take multiple medications, any new supplement should be reviewed for potential interactions.

As always, do not start or stop supplements that might affect blood sugar, blood pressure, or lipids without talking to a clinician who knows your medical history.

Reference

The study and abstract are available here: Lipid-lowering effect of alpha-lipoic acid: A systematic review and meta-analysis of randomized controlled trials.